Search - tctmd.com

Displaying 81 - 100 of 1107

Sort: Relevancy | Date

Presentation THT 2025

Myocardial Intramural Remodeling by Transvenous Tether (MIRTH)

Presenter: Chris Bruce

February 12, 2025

Presentation THT 2025

Win Ratio Analysis of Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: REBALANCE-HF Randomized Trial

Presenter: Marat Fudim

February 12, 2025

Presentation THT 2025

Ventricular Remodeling as an Endpoint for HF Trials: Methods, Comparative Precision, Real-World Applicability

Presenter: Joao Cavalcante

February 12, 2025

Presentation THT 2025

Use of AI-Based Automated Detection of Clinically Significant VHD From Echocardiography

Presenter: Akhil Narang

February 12, 2025

Presentation THT 2025

Trials and Tribulations of Xeno-Transplant

Presenter: Albert Hicks

February 12, 2025

Presentation THT 2025

Strengths and Weaknesses of VHD Quantitation in Clinical Research and Daily Practice

Presenter: Rebecca Hahn

February 12, 2025

Presentation THT 2025

Sodium Glucose CoTransporter-2 Inhibitor Following Left Ventricular Assist Device Implantation: A Randomized Controlled Trial

Presenter: Mary Acosta

February 12, 2025

Presentation THT 2025

Role of Molecular Biopsy in Precision Rejection Diagnosis

Presenter: Andrea Fernandez-Valledor

February 12, 2025

Presentation THT 2025

Relationship Between Pulmonary Artery Diastolic Pressure and Blood Volume in Supine or Seated Positions

Presenter: Paula Rambarat

February 12, 2025

Presentation THT 2025

Performance of a Remote Speech Analysis Technology to Detect Worsening Heart Failure Events in Ambulatory Patients With Heart Failure

Presenter: William Abraham

February 12, 2025

Presentation THT 2025

Overview of Residual Risk and Pathophysiological Targets for Devices to Treat Chronic HF

Presenter: Marat Fudim

February 12, 2025

Presentation THT 2025

Novel Therapeutics in Transplant Management: Belatacept, ECP and Everything in Between

Presenter: Nir Uriel

February 12, 2025

Presentation THT 2025

Myeloperoxidase Inhibition in Patients With Ischemic or Non-Ischemic Cardiomyopathy and Heart Failure With Reduced Ejection Fraction (MYSTERY-HF)

Presenter: Simon Braumann

February 12, 2025

Presentation THT 2025

Lessons Learned From RESHAPE-HF-2: An Imager's Perspective

Presenter: Ralph von Bardeleben

February 12, 2025

Presentation THT 2025

Impact of Hemodynamic Testing and Pulmonary Artery Pressure Monitoring on HeartMate 3 RPM and Medication Adjustments: RAMP-IT-UP 3 Study

Presenter: Dor Lotan

February 12, 2025

Presentation THT 2025

Impact of Age on Clinical Outcomes Following HeartMate 3 LVAD Implantation: Insights From the MOMENTUM 3 Trial

Presenter: Nir Uriel

February 12, 2025

Presentation THT 2025

Imaging for Assessing Heart Muscle Disease: State of the Art for Trial Endpoints, Drug Development and Clinical Practice

Presenter: Jonathan Weinsaft

February 12, 2025

Presentation THT 2025

HFpEF: Can Image Phenotyping Help for Prognostication and Therapy DEevelopment

Presenter: Jonathan Cunningham

February 12, 2025

Presentation THT 2025

Greater Splanchnic Nerve Ablation for HFpEF

Presenter: Sheldon Litwin

February 12, 2025

Presentation THT 2025

Effects of AtrioVentricular Interval Modulation (AVIM) Therapy in Subjects With Hypertension and Diastolic Dysfunction

Presenter: Marat Fudim

February 12, 2025

Advertisement

Myocardial Intramural Remodeling by Transvenous Tether (MIRTH)

Win Ratio Analysis of Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: REBALANCE-HF Randomized Trial

Ventricular Remodeling as an Endpoint for HF Trials: Methods, Comparative Precision, Real-World Applicability

Use of AI-Based Automated Detection of Clinically Significant VHD From Echocardiography

Trials and Tribulations of Xeno-Transplant

Strengths and Weaknesses of VHD Quantitation in Clinical Research and Daily Practice

Sodium Glucose CoTransporter-2 Inhibitor Following Left Ventricular Assist Device Implantation: A Randomized Controlled Trial

Role of Molecular Biopsy in Precision Rejection Diagnosis

Relationship Between Pulmonary Artery Diastolic Pressure and Blood Volume in Supine or Seated Positions

Performance of a Remote Speech Analysis Technology to Detect Worsening Heart Failure Events in Ambulatory Patients With Heart Failure

Overview of Residual Risk and Pathophysiological Targets for Devices to Treat Chronic HF

Novel Therapeutics in Transplant Management: Belatacept, ECP and Everything in Between

Myeloperoxidase Inhibition in Patients With Ischemic or Non-Ischemic Cardiomyopathy and Heart Failure With Reduced Ejection Fraction (MYSTERY-HF)

Lessons Learned From RESHAPE-HF-2: An Imager's Perspective

Impact of Hemodynamic Testing and Pulmonary Artery Pressure Monitoring on HeartMate 3 RPM and Medication Adjustments: RAMP-IT-UP 3 Study

Impact of Age on Clinical Outcomes Following HeartMate 3 LVAD Implantation: Insights From the MOMENTUM 3 Trial

Imaging for Assessing Heart Muscle Disease: State of the Art for Trial Endpoints, Drug Development and Clinical Practice

HFpEF: Can Image Phenotyping Help for Prognostication and Therapy DEevelopment

Greater Splanchnic Nerve Ablation for HFpEF

Effects of AtrioVentricular Interval Modulation (AVIM) Therapy in Subjects With Hypertension and Diastolic Dysfunction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content